A9552 Insurance Policy Changes

HCPCS A9552 is officially defined as "Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries." HCPCS A9552 is referenced in 1 tracked payer policy change from Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9552 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Related

All billing codes992129920299213992039921499211

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert